Cardiorenal Outcomes With Ertugliflozin by Baseline Metformin Use: Post Hoc Analyses of the VERTIS CV Trial.

ABSTRACT:

SUBMITTER: Cosentino F 

PROVIDER: S-EPMC9390228 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature